Builds on Long-standing Commitment to Virology Gains Full Rights to Promising Phase II Hepatitis C Biologic, Pegylated-Interferon Lambda Obtains FDA-Approved Specialty Surgical Biologic, RECOTHROM® Attains Early Clinical and Pre-clinical Progr…
Biopharmaceuticals, Mergers & Acquisitions
Bristol-Myers Squibb, ZymoGenetics, Pegylated-Interferon, RECOTHROM, thrombin

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Bristol-Myers Squibb to Acquire ZymoGenetics”
Leave a Comment